Cobblestone Speech Pathology, Shoreham, NY - 11786

Cobblestone Speech Pathology, is categorized under Pathological Laboratories in Shoreham, NY and active since 2005.

Cobblestone Speech Pathology, was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.

If you are seeking more information, feel free to contact Kevin Louser at the company’s single location by writing to 51 Cobblestone Drive, Shoreham, New York NY 11786 or by phoning (631) 744-4191. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cobblestone Speech Pathology,
Contact Person: Kevin Louser
Address: 51 Cobblestone Drive, Shoreham, New York 11786
Phone Number: (631) 744-4191
Annual Revenue (USD): $100.000 to $499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pathological Laboratories
SIC Code: 8071
NAICS Code: 621511
Share This Business:

Cobblestone Speech Pathology, was started in 2005 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Kevin Louser for inquiries that concern Cobblestone Speech Pathology, by calling the company number (631) 744-4191, as your correspondence is most welcome. Additionally, the physical location of the single location of Cobblestone Speech Pathology, can be found at the coordinates 40.930683,-72.88168 as well as the street address 51 Cobblestone Drive in Shoreham, New York 11786.

For its online presence, you may visit Cobblestone Speech Pathology,’s website at and engage with its social media outlets through on Twitter and on Facebook.